I did. You highlighted the approx. 18-36 patients, which it says will be enrolled in the Phase 1B trial. This is correct. But the other patient numbers you highlighted are not in the Phase 1B trial. To repeat, they planned for 18-36 patients and ended up with 24.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
-0.002(10.7%) |
Mkt cap ! $93.33M | |||
| Open | High | Low | Value | Volume |
| 1.3¢ | 1.3¢ | 1.2¢ | $169.9K | 13.68M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 57 | 14920737 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 6817178 | 24 |
View Market Depth
| Last trade - 14.59pm 23/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |